19-382
Showing 1 - 25 of >10,000
Human Immunodeficiency Virus (HIV) Trial in Puerto Rico, United States (ABBV-382, Placebo for ABBV-382)
Recruiting
- Human Immunodeficiency Virus (HIV)
- ABBV-382
- Placebo for ABBV-382
-
Bakersfield, California
- +20 more
Dec 15, 2022
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Placebo)
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- Placebo
-
Glendale, Arizona
- +46 more
Dec 2, 2021
Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions
Completed
- COVID-19
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
COVID-19 Vaccination Trial in Bronx, Brooklyn, New York (Community Health Worker Intervention to Enhance Vaccination Behavior
Recruiting
- COVID-19 Vaccination
- Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB)
-
Bronx, New York
- +3 more
Nov 29, 2023
COVID-19 Pneumonia Trial in L'Hospitalet De Llobregat (Firazyr, SoC)
Completed
- COVID-19 Pneumonia
- Firazyr
- SoC
-
L'Hospitalet De Llobregat, Catalonia, SpainHospital Universitari de Bellvitge
Aug 2, 2022
COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)
Recruiting
- COVID-19
- Renal Insufficiency, Chronic
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 6, 2023
Pregnant Women to- 2 Gether With Rates of Breastfeeding and
Completed
- Breastfeeding
- COVID-19 Infection
- blood prolactin levels
-
Ávila, SpainUniversidad Católica de Ávila
Aug 16, 2022
COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)
Active, not recruiting
- COVID-19
- Lopinavir/Ritonavir 400 mg/100 mg
- Placebo
-
Aurora, Colorado
- +5 more
Aug 17, 2022
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
COVID-19 Admitted at Assiut University Children Hospital
Not yet recruiting
- COVID-19
- (no location specified)
Aug 8, 2022
COVID-19 by Delocalized Biology in the Birth Room
Recruiting
- COVID-19
- Labor
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Genetic Bases of COVID-19 Clinical Variability
Recruiting
- COVID-19
- Massive parallel sequencing of host genome
-
Siena, ItalyUniversity of Siena
Nov 3, 2022
Post-Coronavirus Disease 19 Convalescence at National Institutes
Recruiting
- Post-Coronavirus Disease 19
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 10, 2022
COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)
Recruiting
- COVID-19
- Umbilical cord mesenchymal stem cells implantation
- Comparator
-
Shijiazhuang, Hebei, ChinaThe First Hospital of Hebei Medical University
Feb 22, 2023
COVID 19 Disease Trial in United States (Tafenoquine Oral Tablet, Placebo)
Completed
- COVID 19 Disease
- Tafenoquine Oral Tablet
- Placebo
-
Miami, Florida
- +9 more
Jan 13, 2023
Interleukin 6 Receptor Antagonists in Corona Virus Disease 19
Recruiting
- Corona Virus Infection
- ELISA
-
Assiut, EgyptAssiutU
Feb 2, 2023
SARS-COV2 (COVID-19) Persistence After Convalescence
Recruiting
- COVID-19
- +2 more
-
New York, New YorkColumbia University Medical Center
Jul 19, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Cytokine Release Syndrome, Covid-19 Trial in Sao Luis (Tocilizumab 180 MG/ML, Methylprednisolone Sodium Succinate)
Terminated
- Cytokine Release Syndrome
- Covid-19
- Tocilizumab 180 MG/ML
- Methylprednisolone Sodium Succinate
-
Sao Luis, MA, BrazilHospital Sao Domingos
Mar 14, 2022
Cardiac Arrhythmias In Coronavirus Disease (COVID-19)
Recruiting
- COVID 19 Cardiac
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 11, 2022
COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )
Terminated
- COVID
- +2 more
- Convalescent anti-SARS-CoV-2 plasma
- Infusion placebo
-
Aalborg, Denmark
- +11 more
Aug 2, 2022
Covid19 Trial in Philippines (Artecom® (pyronaridine-artesunate), Placebo)
Recruiting
- Covid19
- Artecom® (pyronaridine-artesunate)
- Placebo
-
Dasmariñas, Gov, D. Mangubat St, 4114 Cavite, Philippines
- +3 more
Sep 28, 2021
187 Critically Ill Coronavirus Disease 2019 (COVID-19)
Completed
- COVID-19
- demographic and clinical data obtained from hospital's electronic medical record.
-
Sao Luis, MA, BrazilHospital Sao Domingos
Mar 14, 2022